Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Testosterone is crucial for development, growth, and various body functions in mammals.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Green algae can break down finasteride, reducing environmental harm.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.